
    
      In This open -label study, patients in ICU with acute kidney injury are randomized to either
      midodrine tablets or placebo. the number of intradialytic episodes and both systolic and
      diastolic blood pressure between both groups are compared. Mortality and adverse effects are
      monitored and compared as well.
    
  